Abstract:Objective To evaluate the feasibility of de tecting epidermal growth factor receptor (EGFR) mRNA by reverse transcription po lymerase chain reaction(RT-PCR)in peripheral blood of patients with breast cance r and to explore its significance. Methods RT-PCR assay w as applied to detect the expression of EGFR mRNA in the peripheral blood of 40 p atients with breast cancer and in 30 healthy donors. The result of EGFR mRNA was compared with that of known marker of circulating epithelial cells:CK-19. Results In peripheral blood from 30 healthy donors,none of EGF R mRNA was detected,but the positivity of CK19 mRNA expression was 26.7% (8/ 30) .In contrast ,EGFR mRNA was detected in 13 of 40(32.5%)patients with breast canc er,compared with healthy donors (P0.01),there was significant d ifference between the two groups. CK-19 mRNA was found in 14 of 40(35.0%), compa red with healthy donors (P0.05) and there was no statistical di fference. On the other hand, the expression of EGFR was observed in 25(62.5%) of tumor tissues by immunohistochemistry. We found that all patients who expressed EGFR mRNA in peripheral blood were also expressing EGFR in primary tumors. Pati ents with a high expression of EGFR in tumoral breast tissues display high expre ssion of EGFR in peripheral blood as well(P0.01). EGFR mRNA w as expressed in 5 of 26(19.2%) breast cancer patients without any treatments bef ore, but the positivity for EGFR mRNA expression was 57.1% (8/ 14) in breast can cer patients who have received treatments before. There is significant differenc e between two groups above (P0.05). Expression of EGFR mRNA was detected in 1of 6 (16.7%) metastatic breast cancer patients who have received P aclitaxel involved salvage chemotherapy, however, the positivity for EGFR mRNA e xpression was 87.5% (7/ 8) in them who have never received Paclitaxel contained salvage chemotherapy, there was significant difference between two groups ( P0.05). Conclusion CK-19 mR NA showed no dia gnostic value as marker of circulating tumor cells in breast cancers. However, E GFR mRNA in blood may be a useful marker of circulating tumor cells in breast ca ncers. Detecting EGFR mRNA in peripheral blood of patients with breast cancer us ing RT-PCR can be used as a prognostic indicator. Paclitaxel may reduce the risk of relapse and metastasis of breast cancer.

Rapid Detection of HLA Genes Expression in Peripheral Blood Mononuclear Cell of Gastric Cancer Patients by Reverse Transcriptase Polymerase Chain Reaction

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF CYTOKERATIN 20 mRNA IN CENTRAL VEIN BLOOD OF PATIENTS WITH GASTRIC CANCER BY RT-PCR

Primary Application of Genechip for Detecting Interleukin-1B Susceptibility Gene of Gastric Cancer

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients

The Expression of Human Macrophage Metalloelastase Mrna in Gastric Cancer Cell Lines and Tissues and Its Clinical Significance

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer

The Preliminary Analysis of Peripheral Blood Microrna Expression Profile of Gastric Cancer

Mrna of MAGE Genes As Specific Markers in Detection of Tumor Cells in the Peripheral Blood of Patients with Hepatocellular Carcinoma

Molecular Detection of Disseminated Tumor Cells in the Peripheral Blood of Patients with Gastric Cancer: Evaluation of Their Prognostic Significance

Identification of Differentially Expressed Genes in the Gastric Cancer Patient by Laser Microdissection and Cdna Microarray

Differential gene expression profiles of gastric cancer]

Expression of HLA-G in Patients with Hepatocellular Carcinoma.

Expressions of MAGE-A 3, MAGE-A 6 and MAGE-A 10 genes in peripheral blood of patients with colorectal carcinoma and their clinical signi cance

Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker

[PLAC1/CP1 Gene Expression and Autologous Humoral Immunity in Gastric Cancer Patients].

Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers

Can the Analysis of Toll-like Receptors (TLR) on NK and NKT-like Cells Improve Gastric Cancer Diagnostics and Treatment?

Long non-coding RNA expression profile in human gastric cancer and its clinical significances

Detection of Cytokeratin 19 (CK19) Mrna and Human Papillomavirus Type 16 (HPV16) Mrna in Peripheral Blood of Cervical Cancer Patients and Its Significance

Comparative Study of Detection of Epidermal Growth Factor Receptor and Cytokeratin - 19 Mrna in Peripheral Blood of Breast Cancer Patients by Reverse Transcription Polymerase Chain Reaction